s 20928 has been researched along with glucagon in 1 studies
| Studies (s 20928) | Trials (s 20928) | Recent Studies (post-2010) (s 20928) | Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 26,039 | 1,498 | 3,054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bizot-Espiard, JG; Chun, SJ; Guardiola-Lemaitre, B; Hosokawa, M; Nagai, K; Niijima, A; Shima, T | 1 |
1 other study(ies) available for s 20928 and glucagon
| Article | Year |
|---|---|
Melatonin suppresses hyperglycemia caused by intracerebroventricular injection of 2-deoxy-D-glucose in rats.
Topics: Animals; Blood Glucose; Cerebral Ventricles; Deoxyglucose; Glucagon; Hyperglycemia; Injections, Intraperitoneal; Injections, Intraventricular; Insulin; Insulin Secretion; Male; Melatonin; Naphthalenes; Rats; Rats, Wistar | 1997 |